| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $28K | — | — |
| Cost of Revenue | $23K | — | — |
| Gross Profit | $6K | — | — |
| R&D Expense | $297K | — | +12.8% |
| SG&A Expense | $1.0M | — | -93.2% |
| Operating Income | -$1.6M | — | +89.4% |
| Interest Expense | $290K | — | +0.0% |
| Pre-tax Income | -$3.2M | — | +79.8% |
| Net Income | -$3.2M | — | +79.8% |
| EPS (Basic) | -$20.57 | — | +95.9% |
| EPS (Diluted) | -$20.57 | — | +95.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $5.9M | +483.4% | — |
| Inventory | $370K | +46.1% | — |
| Current Assets | $7.1M | +442.4% | +262.1% |
| Total Assets | $7.1M | +442.4% | +262.1% |
| Current Liabilities | $3.2M | -58.5% | -64.5% |
| Total Liabilities | $3.2M | -57.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.0M | — | -73.5% |
| Financing Cash Flow | $7.9M | — | +155.0% |
| -63.6% |
| Stockholders' Equity | $3.9M | +160.7% | +155.6% |